Literature DB >> 5325201

Double-blind evaluation of a new treatment for Ménière's syndrome.

J C Elia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5325201

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Betahistine for Menière's disease or syndrome.

Authors:  A L James; M J Burton
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 2.  Menière's disease.

Authors:  Adrian L James; Marc A Thorp
Journal:  BMJ Clin Evid       Date:  2007-03-01

3.  Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo.

Authors:  Jozef J P Nauta
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-19       Impact factor: 2.503

4.  Betahistine.

Authors:  A Biswas
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1997-04

Review 5.  Ménière's disease. A practical approach to management.

Authors:  G B Brookes
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

6.  Inhibitory effect of betahistine on polysynaptic neurons in the lateral vestibular nucleus.

Authors:  H Unemoto; M Sasa; S Takaori; J Ito; I Matsuoka
Journal:  Arch Otorhinolaryngol       Date:  1982

7.  Betahistine hydrochloride in Méniére's disease.

Authors:  I J Frew; G N Menon
Journal:  Postgrad Med J       Date:  1976-08       Impact factor: 2.401

8.  The effect of betahistine on gastric acid secretion and mucosal blood flow in conscious dogs.

Authors:  B P Curwain; P Holton; J Spencer
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

Review 9.  Betahistine for symptoms of vertigo.

Authors:  Louisa Murdin; Kiran Hussain; Anne G M Schilder
Journal:  Cochrane Database Syst Rev       Date:  2016-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.